Scientific Advisory Board
We draw upon the expertise of over 300 clinicians and medtech executives.
Katherine Crothall
Katherine is the founder of Animas LLC, Luxar Corp., and Laakmann Electro-Optics, Inc. She is a Director of Cortechs AI, and Moving iMage Technologies, Inc. Katherine holds degrees from the University of Pennsylvania and the University of Southern California.
Hannah Mamuszka
Hannah Mamuszka is Chief Executive Officer at Alva10. A laboratory scientist trained at Harvard, she led some of the earliest deals in Precision Medicine starting in 2004. Hannah is a pioneering leader in the advancement of diagnostics and data as transformative tools to improve healthcare and longevity.
She is also a prominent speaker on the utilization of patient-specific data in healthcare decision-making, highlighting its significant role in enhancing longevity, improving overall health outcomes, and reducing healthcare costs.
In 2016 she founded Alva10 to focus on commercial strategy and payment models for diagnostics to improve patient access to existing and novel technology. Alva10 is the leader in diagnostic market access in the commercial and employer space, having brought many new technologies to the market through novel payment models, economic analysis, policy, and healthcare system reform across disease areas and regions. She serves on the editorial board of the Journal of Precision Medicine and is a director at Bionano Genomics (BNGO), Centile Bio, and UNC’s Carolina Health Informatics Program (CHIP), where she advises on data strategy and analytics in healthcare.
Dr. Pasquale Petrera, MD
Fellowship-trained in hip and knee reconstruction, Dr. Petrera is a board certified orthopedic surgeon who specializes in joint replacement and osteoarthritis. He is also the director of the Joint Replacement Center at TidalHealth Peninsula Regional.
Dr. Petrera is active in the medical community and involved in ongoing research on hip and knee replacement, including degenerative conditions affecting those joints. He is a frequent contributor of papers and lectures at conferences and universities.
Dr. Petrera received his medical degree from Albany Medical College in New York. He completed his internship in general surgery and his residency in orthopedic surgery at Albany Medical Center Hospital, and completed his fellowship at the University of Pittsburgh Department of Orthopedic Surgery and Adult Reconstructive Surgery.
Dr. Robert Wilson, MD
Dr. Wilson is an interventional cardiologist and Professor of Medicine who previously led the interventional cardiology program at the University of Minnesota. He has extensive experience in medical device and business development. Dr. Wilson previously founded and led three medical device companies: Acist Medical Systems (diagnostic interventional cardiology equipment), HLT (transcatheter heart valve), and Egg Medical (radiation protection platform), where he is the Chief Executive Officer and Chairman.
